Influx Healthtech Ltd IPO Price Range is ₹91 - 96, with a minimum investment of ₹1,15,200 for 1200 shares.
₹1,15,200
/ 1200 shares
Minimum Investment
View Influx Healthtech Ltd IPO details including price range, minimum investment, lot size, financials, and IPO timeline. Get subscription updates, peer comparison, and key insights to help you make an informed decision.
IPO Status
Price Band
₹91 - 96
Open Date
2025-06-18
Close Date
2025-06-20
IPO Size
₹58.57 Cr
Lot Size
1200 shares
Min Investment
₹1,15,200
Listing Exchange
NSE
IPO subscribed over
🚀 187.32x
This IPO has been subscribed by 117.703x in the retail category and 137.87x in the QIB category.
Total Subscription | 187.32x |
Retail Individual Investors | 117.703x |
Qualified Institutional Buyers | 137.87x |
Non Institutional Investors | 481.469x |
Name | Influx Healthtech Ltdx |
Diverse client base with longstanding CDMO relationships.
Well versed and equipped advanced manufacturing facilities with global accreditations.
Large and rapidly growing R&D capabilities across our product portfolio.
Experienced Promoter and management team with strong industry expertise and successful track record.
Robust Quality Assurance & Control practices.
Proven Track record of growth and profitability.
The Company is reliant on the demand from the nutraceutical industry for a significant portion of its revenue. Any downturn in the nutraceutical industry or an inability to increase or effectively manage its sales could have an adverse impact on the Companys business and results of operations.
Its existing manufacturing facility are concentrated in a single region i.e., Palghar, Thane, Maharashtra and the inability to operate and grow its business in this particular region may have an adverse effect on its business, financial condition, results of operations, cash flows and future business prospects.
The Company is dependent on few numbers of customers for sales. Loss of any of this large customer may affect its revenues and profitability.
The company has historically derived, and may continue to derive, a signification of its supply from top 10 Suppliers. Also, the Company has not entered into long-term agreements with these suppliers. In the event the company is unable to procure adequate amounts of raw materials, at competitive prices its business, results of operations and financial condition may be adversely affected.
Too much Geographical concentration of its Business on specific location can impact the company Business.
Its reliance on certain industries for a significant portion of its sales could have an adverse effect on its business.
The company has not taken any steps to order the machinery/equipment required for the proposed expansion. In the event of any delay in placing the orders, or in the event the vendors are not able to provide the equipment / machineries in a timely manner, or at all, the same may result in time and cost over-runs.
Its business activities are exposed to fluctuations in the prices of raw materials.
Its may face several risks associated with the construction of the building of the Proposed Expansion, which could hamper its growth, prospects, cash flows and business and financial condition.
Its Registered Office, Factory Units and Godown is located on premises which are not owned by it and has been obtained on license basis from the promoters of the company. Disruption of its rights as licensee/ lessee or termination of the agreements with its licensors/ lessors (promoters) may adversely impact its operations and, consequently, its business, financial condition and results of operations.
1
Download the INDmoney app and complete your KYC to open an account.
2
Go to the INDstocks section and tap on IPO, or search for ‘IPO’.
3
Select Influx Healthtech Ltd IPO from the list of live IPOs.
4
View key details like price band, lot size, and dates, then tap ‘Apply Now’.
5
Choose the number of lots and place your order via UPI.
6
Your funds will be blocked until the share allotment is finalized.